Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Source:http://linkedlifedata.com/resource/pubmed/id/17075126

J. Clin. Oncol. 2006 Nov 1 24 31 5070-8

Download in:

View as

General Info

PMID
17075126